Skip to main content
Erschienen in: Clinical Research in Cardiology 7/2014

01.07.2014 | Review

Hypertension and hypertensive heart disease in African women

verfasst von: Karen Sliwa, Dike Ojji, Katrin Bachelier, Michael Böhm, Albertino Damasceno, Simon Stewart

Erschienen in: Clinical Research in Cardiology | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Hypertension and hypertensive heart disease is one of the main contributors to a growing burden of non-communicable forms of cardiovascular disease around the globe. The recently published global burden of disease series showed a 33 % increase of hypertensive disorders in pregnancy in the past two decades with long-term consequences. Africans, particularly younger African women, appear to be bearing the brunt of this increasing public health problem. Hypertensive heart disease is particularly problematic in pregnancy and is an important contributor to maternal case-fatality. European physicians increasingly need to attend to patients from African decent and need to know about unique aspects of disease presentation and pharmacological as well as non-pharmacological care. Reductions in salt consumption, as well as timely detection and treatment of hypertension and hypertensive heart disease remain a priority for effective primary and secondary prevention of CVD (particularly stroke and CHF) in African women. This article reviews the pattern, potential causes and consequences and treatment of hypertension and hypertensive heart disease in African women, identifying the key challenges for effective primary and secondary prevention in this regard.
Literatur
1.
Zurück zum Zitat He FJ, MacGregor GA (2007) Blood pressure is the most important cause of death and disability in the world. Eur Heart J Suppl 9:B23–B28CrossRef He FJ, MacGregor GA (2007) Blood pressure is the most important cause of death and disability in the world. Eur Heart J Suppl 9:B23–B28CrossRef
3.
Zurück zum Zitat Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, Gillespie C, Merritt R, Hu FB (2012) Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA 307:1273–1283PubMedCrossRef Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, Gillespie C, Merritt R, Hu FB (2012) Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA 307:1273–1283PubMedCrossRef
4.
Zurück zum Zitat Law M, Morris J, Wald N (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:1245–1253 Law M, Morris J, Wald N (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:1245–1253
5.
Zurück zum Zitat Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K (2007) The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370:1929–1938PubMedCrossRef Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K (2007) The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370:1929–1938PubMedCrossRef
6.
Zurück zum Zitat Sliwa K, Stewart S, Gersh BJ (2011) Hypertension a global perspective. Circulation 123:2892–2896PubMedCrossRef Sliwa K, Stewart S, Gersh BJ (2011) Hypertension a global perspective. Circulation 123:2892–2896PubMedCrossRef
7.
Zurück zum Zitat Gersh BJ, Sliwa K, Mayosi BM, Yusuf S (2010) Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J 31:642–648PubMedCrossRef Gersh BJ, Sliwa K, Mayosi BM, Yusuf S (2010) Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J 31:642–648PubMedCrossRef
8.
Zurück zum Zitat Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D (2009) The burden of non-communicable diseases in South Africa. Lancet 374:934–947PubMedCrossRef Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D (2009) The burden of non-communicable diseases in South Africa. Lancet 374:934–947PubMedCrossRef
9.
Zurück zum Zitat Njelekela MA, Mpembeni R, Muhihi A, Mligiliche NL, Spiegelman D, Hertzmark E, Liu E, Finkelstein JL, Fawzi WW, Willett WC, Mtabaji J (2009) Gender-related differences in the prevalence of cardiovascular disease risk factors and their correlates in urban Tanzania. BMC Cardiovasc Disord 9:30PubMedCentralPubMedCrossRef Njelekela MA, Mpembeni R, Muhihi A, Mligiliche NL, Spiegelman D, Hertzmark E, Liu E, Finkelstein JL, Fawzi WW, Willett WC, Mtabaji J (2009) Gender-related differences in the prevalence of cardiovascular disease risk factors and their correlates in urban Tanzania. BMC Cardiovasc Disord 9:30PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Stewart S, Carrington M, Pretorius S, Methusi P, Sliwa K (2011) Standing at the crossroads between new and historically prevalent heart disease: effects of migration and socio-economic factors in the Heart of Soweto cohort study. Eur Heart J 32:492–499PubMedCrossRef Stewart S, Carrington M, Pretorius S, Methusi P, Sliwa K (2011) Standing at the crossroads between new and historically prevalent heart disease: effects of migration and socio-economic factors in the Heart of Soweto cohort study. Eur Heart J 32:492–499PubMedCrossRef
11.
Zurück zum Zitat Cooper RS, Osotimehin B, Kaufman JS, Forrester T (1998) Disease burden in sub-Saharan Africa: what should we conclude in the absence of data? Lancet 351:208–210PubMedCrossRef Cooper RS, Osotimehin B, Kaufman JS, Forrester T (1998) Disease burden in sub-Saharan Africa: what should we conclude in the absence of data? Lancet 351:208–210PubMedCrossRef
12.
Zurück zum Zitat Addo J, Smeeth L, Leon DA (2007) Hypertension in sub-saharan Africa: a systematic review. Hypertension 50:1012–1018PubMedCrossRef Addo J, Smeeth L, Leon DA (2007) Hypertension in sub-saharan Africa: a systematic review. Hypertension 50:1012–1018PubMedCrossRef
13.
Zurück zum Zitat Stewart S, Carrington MJ, Pretorius S, Ogah OS, Blauwet L, Antras-Ferry J, Sliwa K (2012) Elevated risk factors but low burden of heart disease in urban African primary care patients: a fundamental role for primary prevention. Int J Cardiol 158:2005–2010CrossRef Stewart S, Carrington MJ, Pretorius S, Ogah OS, Blauwet L, Antras-Ferry J, Sliwa K (2012) Elevated risk factors but low burden of heart disease in urban African primary care patients: a fundamental role for primary prevention. Int J Cardiol 158:2005–2010CrossRef
14.
Zurück zum Zitat Selassie A, Wagner CS, Laken ML, Ferguson ML, Ferdinand KC, Egan BM (2011) Progression is accelerated from prehypertension to hypertension in blacks. Hypertension 58:579–587PubMedCentralPubMedCrossRef Selassie A, Wagner CS, Laken ML, Ferguson ML, Ferdinand KC, Egan BM (2011) Progression is accelerated from prehypertension to hypertension in blacks. Hypertension 58:579–587PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S (2008) Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371:915–922PubMedCrossRef Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S (2008) Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371:915–922PubMedCrossRef
16.
Zurück zum Zitat Olatunbosun ST, Kaufman JS, Cooper RS, Bella AF (2000) Hypertension in a black population: prevalence and biosocial determinants of high blood pressure in a group of urban Nigerians. J Hum Hypertens 14:249–257PubMedCrossRef Olatunbosun ST, Kaufman JS, Cooper RS, Bella AF (2000) Hypertension in a black population: prevalence and biosocial determinants of high blood pressure in a group of urban Nigerians. J Hum Hypertens 14:249–257PubMedCrossRef
17.
Zurück zum Zitat Salako BL, Ogah OS, Adebiyi AA, Adedapo KS, Bekibele CO, Oluleye TS, Okpechi I (2007) Unexpectedly high prevalence of target-organ damage in newly diagnosed Nigerians with hypertension. Cardiovasc J Afr 18:77–83PubMed Salako BL, Ogah OS, Adebiyi AA, Adedapo KS, Bekibele CO, Oluleye TS, Okpechi I (2007) Unexpectedly high prevalence of target-organ damage in newly diagnosed Nigerians with hypertension. Cardiovasc J Afr 18:77–83PubMed
18.
Zurück zum Zitat Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, Jinagouda S, Shea S (2004) Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens 17:963–970PubMedCrossRef Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, Jinagouda S, Shea S (2004) Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens 17:963–970PubMedCrossRef
19.
Zurück zum Zitat Akinkugbe OO, Ojo AO (1968) The systemic blood pressure in a rural Nigerian population. Trop Geogr Med 20:347–356PubMed Akinkugbe OO, Ojo AO (1968) The systemic blood pressure in a rural Nigerian population. Trop Geogr Med 20:347–356PubMed
20.
Zurück zum Zitat Ogah OS (2006) Hypertension in sub-Saharan African populations: the burden of hypertension in Nigeria. Ethn Dis 16:765PubMed Ogah OS (2006) Hypertension in sub-Saharan African populations: the burden of hypertension in Nigeria. Ethn Dis 16:765PubMed
21.
Zurück zum Zitat Onwubere BJ, Ejim EC, Okafor CI, Emehel A, Mbah AU, Onyia U, Mendis S (2011) Pattern of blood pressure indices among the residents of a rural community in South East Nigeria. Int J Hypertens 2011:621074PubMedCentralPubMedCrossRef Onwubere BJ, Ejim EC, Okafor CI, Emehel A, Mbah AU, Onyia U, Mendis S (2011) Pattern of blood pressure indices among the residents of a rural community in South East Nigeria. Int J Hypertens 2011:621074PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Peer N, Steyn K, Dennison CR, Levitt NS, Nyo MT, Nel JH, Commerford PJ, Fourie JM, Hill MN (2008) Determinants of target organ damage in black hypertensive patients attending primary health care services in Cape Town: the Hi–Hi study. Am J Hypertens 21:896–902PubMedCrossRef Peer N, Steyn K, Dennison CR, Levitt NS, Nyo MT, Nel JH, Commerford PJ, Fourie JM, Hill MN (2008) Determinants of target organ damage in black hypertensive patients attending primary health care services in Cape Town: the Hi–Hi study. Am J Hypertens 21:896–902PubMedCrossRef
23.
Zurück zum Zitat Stewart S, Libhaber E, Carrington M, Damasceno A, Abbasi H, Hansen C, Wilkinson D, Sliwa K (2011) The clinical consequences and challenges of hypertension in urban-dwelling black Africans: insights from the Heart of Soweto Study. Int J Cardiol 146:22–27PubMedCrossRef Stewart S, Libhaber E, Carrington M, Damasceno A, Abbasi H, Hansen C, Wilkinson D, Sliwa K (2011) The clinical consequences and challenges of hypertension in urban-dwelling black Africans: insights from the Heart of Soweto Study. Int J Cardiol 146:22–27PubMedCrossRef
24.
Zurück zum Zitat Huxley R, Neil A, Collins R (2002) Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? Lancet 360:659–665PubMedCrossRef Huxley R, Neil A, Collins R (2002) Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? Lancet 360:659–665PubMedCrossRef
25.
Zurück zum Zitat Kruger R, Kruger HS, Macintyre UE (2006) The determinants of overweight and obesity among 10- to 15-year-old schoolchildren in the North West Province, South Africa-the THUSA BANA (Transition and Health during Urbanisation of South Africans; BANA, children) study. Public Health Nutr 9:351–358PubMedCrossRef Kruger R, Kruger HS, Macintyre UE (2006) The determinants of overweight and obesity among 10- to 15-year-old schoolchildren in the North West Province, South Africa-the THUSA BANA (Transition and Health during Urbanisation of South Africans; BANA, children) study. Public Health Nutr 9:351–358PubMedCrossRef
26.
Zurück zum Zitat Cruickshank JK, Mzayek F, Liu L, Kieltyka L, Sherwin R, Webber LS, Srinavasan SR, Berenson GS (2005) Origins of the “black/white” difference in blood pressure: roles of birth weight, postnatal growth, early blood pressure, and adolescent body size: the Bogalusa heart study. Circulation 111:1932–1937PubMedCrossRef Cruickshank JK, Mzayek F, Liu L, Kieltyka L, Sherwin R, Webber LS, Srinavasan SR, Berenson GS (2005) Origins of the “black/white” difference in blood pressure: roles of birth weight, postnatal growth, early blood pressure, and adolescent body size: the Bogalusa heart study. Circulation 111:1932–1937PubMedCrossRef
27.
Zurück zum Zitat Barker DJP (1998) Mothers, babies and health in later life, 2nd edn. Churchill Livingstone, pp 1–127 Barker DJP (1998) Mothers, babies and health in later life, 2nd edn. Churchill Livingstone, pp 1–127
28.
Zurück zum Zitat Seely EW, Ecker J (2011) Clinical practice. Chronic hypertension in pregnancy. N Engl J Med 365:439–446PubMedCrossRef Seely EW, Ecker J (2011) Clinical practice. Chronic hypertension in pregnancy. N Engl J Med 365:439–446PubMedCrossRef
29.
Zurück zum Zitat Karthikeyan VJ, Blann AD, Baghdadi S, Lane DA, Gareth Beevers D, Lip GY (2011) Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor. Clin Res Cardiol 100:531–537PubMedCrossRef Karthikeyan VJ, Blann AD, Baghdadi S, Lane DA, Gareth Beevers D, Lip GY (2011) Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor. Clin Res Cardiol 100:531–537PubMedCrossRef
30.
Zurück zum Zitat Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, Ansari AA (2006) Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 27:441–446PubMedCrossRef Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, Ansari AA (2006) Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 27:441–446PubMedCrossRef
31.
Zurück zum Zitat Sliwa K, Hilfiker-Kleiner D, Petrie M, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi B, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray J (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Eur J Heart Fail 12:767–778PubMedCrossRef Sliwa K, Hilfiker-Kleiner D, Petrie M, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi B, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray J (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Eur J Heart Fail 12:767–778PubMedCrossRef
32.
Zurück zum Zitat Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A (2005) Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111:2050–2055PubMedCrossRef Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A (2005) Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111:2050–2055PubMedCrossRef
33.
Zurück zum Zitat Duran N, Gunes H, Duran I, Biteker M, Ozkan M (2008) Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet 101:137–140PubMedCrossRef Duran N, Gunes H, Duran I, Biteker M, Ozkan M (2008) Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet 101:137–140PubMedCrossRef
34.
Zurück zum Zitat Fett JD, Christie LG, Carraway RD, Murphy JG (2005) Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 80:1602–1606PubMedCrossRef Fett JD, Christie LG, Carraway RD, Murphy JG (2005) Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 80:1602–1606PubMedCrossRef
35.
Zurück zum Zitat Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 322:1561–1566PubMedCrossRef Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 322:1561–1566PubMedCrossRef
36.
Zurück zum Zitat Koren MJ, Ulin RJ, Koren AT, Laragh JH, Devereux RB (2002) Left ventricular mass change during treatment and outcome in patients with essential hypertension. Am J Hypertens 15:1021–1028PubMedCrossRef Koren MJ, Ulin RJ, Koren AT, Laragh JH, Devereux RB (2002) Left ventricular mass change during treatment and outcome in patients with essential hypertension. Am J Hypertens 15:1021–1028PubMedCrossRef
37.
Zurück zum Zitat Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS, Lorell BH (1999) Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 34:264–273PubMedCrossRef Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS, Lorell BH (1999) Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 34:264–273PubMedCrossRef
38.
Zurück zum Zitat Vasan RS, Evans JC, Benjamin EJ, Levy D, Larson MG, Sundstrom J, Murabito JM, Sam F, Colucci WS, Wilson PW (2004) Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study. Hypertension 43:957–962PubMedCrossRef Vasan RS, Evans JC, Benjamin EJ, Levy D, Larson MG, Sundstrom J, Murabito JM, Sam F, Colucci WS, Wilson PW (2004) Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study. Hypertension 43:957–962PubMedCrossRef
39.
Zurück zum Zitat Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, Sliwa K (2008) Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation 118:2360–2367PubMedCrossRef Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, Sliwa K (2008) Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation 118:2360–2367PubMedCrossRef
40.
Zurück zum Zitat Opie LH, Seedat YK (2005) Hypertension in sub-Saharan African populations. Circulation 112:3562–3568PubMedCrossRef Opie LH, Seedat YK (2005) Hypertension in sub-Saharan African populations. Circulation 112:3562–3568PubMedCrossRef
41.
Zurück zum Zitat Libhaber EN, Libhaber CD, Candy GP, Sliwa K, Kachope J, Hlatshwayo NM, Puane MO, Woodiwiss AJ, Norton GR, Essop MR, Sareli P (2004) Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry. Am J Hypertens 17:428–432PubMedCrossRef Libhaber EN, Libhaber CD, Candy GP, Sliwa K, Kachope J, Hlatshwayo NM, Puane MO, Woodiwiss AJ, Norton GR, Essop MR, Sareli P (2004) Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry. Am J Hypertens 17:428–432PubMedCrossRef
42.
Zurück zum Zitat Skudicky D, Sareli P, Libhaber E, Candy G, Radevski I, Valtchanova Z, Tshele E, Thijs L, Wang JG, Staessen JA (2002) Relationship between treatment-induced changes in left ventricular mass and blood pressure in black African hypertensive patients: results of the Baragwanath Trial. Circulation 105:830–836PubMedCrossRef Skudicky D, Sareli P, Libhaber E, Candy G, Radevski I, Valtchanova Z, Tshele E, Thijs L, Wang JG, Staessen JA (2002) Relationship between treatment-induced changes in left ventricular mass and blood pressure in black African hypertensive patients: results of the Baragwanath Trial. Circulation 105:830–836PubMedCrossRef
43.
Zurück zum Zitat Kotchen TA, Kotchen JM, Grim CE, Krishnaswami S, Kidambi S (2009) Aldosterone and alterations of hypertension-related vascular function in African Americans. Am J Hypertens 22:319–324PubMedCrossRef Kotchen TA, Kotchen JM, Grim CE, Krishnaswami S, Kidambi S (2009) Aldosterone and alterations of hypertension-related vascular function in African Americans. Am J Hypertens 22:319–324PubMedCrossRef
44.
Zurück zum Zitat Rodrigues SL, Angelo LC, Baldo MP, Dantas EM, Barcelos AM, Pereira AC, Krieger JE, Mill JG (2013) Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study. Clin Res Cardiol 102:653–659PubMedCrossRef Rodrigues SL, Angelo LC, Baldo MP, Dantas EM, Barcelos AM, Pereira AC, Krieger JE, Mill JG (2013) Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study. Clin Res Cardiol 102:653–659PubMedCrossRef
45.
Zurück zum Zitat Sliwa K, Lee G, Carrington M, Obel P, Okreglicki A, Stewart S (2013) Redefining the ECG in urban South Africans: electrocardiographic findings in heart disease-free Africans. Int J Cardiol 167:2204–2209 Sliwa K, Lee G, Carrington M, Obel P, Okreglicki A, Stewart S (2013) Redefining the ECG in urban South Africans: electrocardiographic findings in heart disease-free Africans. Int J Cardiol 167:2204–2209
46.
Zurück zum Zitat Galasko G, Collinson PO, Barnes SC, Gaze D, Lahiri A, Senior R (2007) Comparison of the clinical utility of atrial and B type natriuretic peptide measurement for the diagnosis of systolic dysfunction in a low-risk population. J Clin Pathol 60:570–572PubMedCentralPubMedCrossRef Galasko G, Collinson PO, Barnes SC, Gaze D, Lahiri A, Senior R (2007) Comparison of the clinical utility of atrial and B type natriuretic peptide measurement for the diagnosis of systolic dysfunction in a low-risk population. J Clin Pathol 60:570–572PubMedCentralPubMedCrossRef
47.
Zurück zum Zitat Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB (2003) Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 361:717–725PubMedCrossRef Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB (2003) Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 361:717–725PubMedCrossRef
48.
Zurück zum Zitat Kolo P, Omotoso A, Katibi I, Sanya E, Adamu U, Fasae A, Aigbe I (2008) Gender differences in left ventricular size and geometric pattern of hypertension subjects. Cardiology 4:11–15 Kolo P, Omotoso A, Katibi I, Sanya E, Adamu U, Fasae A, Aigbe I (2008) Gender differences in left ventricular size and geometric pattern of hypertension subjects. Cardiology 4:11–15
49.
Zurück zum Zitat Montgomery AA, Fahey T, Peters TJ, MacIntosh C, Sharp DJ (2000) Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ 320:686–690PubMedCentralPubMedCrossRef Montgomery AA, Fahey T, Peters TJ, MacIntosh C, Sharp DJ (2000) Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ 320:686–690PubMedCentralPubMedCrossRef
50.
Zurück zum Zitat Steyn K, Fourie J, Temple N (2006) Chronic diseases of lifestyle in South Africa: 1995–2005. South African Medical Research Council, Cape Town Steyn K, Fourie J, Temple N (2006) Chronic diseases of lifestyle in South Africa: 1995–2005. South African Medical Research Council, Cape Town
51.
Zurück zum Zitat Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T (2010) Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 3:CD005182 Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T (2010) Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 3:CD005182
52.
Zurück zum Zitat Shulman N, Tuttle E Jr, Entwisle G, Apostolides A, Oberman A, Schnaper HW, Kass EH, Taylor JO, Polk BF, Stamler J (1988) Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. JAMA 259:2113–2122CrossRef Shulman N, Tuttle E Jr, Entwisle G, Apostolides A, Oberman A, Schnaper HW, Kass EH, Taylor JO, Polk BF, Stamler J (1988) Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. JAMA 259:2113–2122CrossRef
53.
Zurück zum Zitat Charlton KE, Steyn K, Levitt NS, Zulu JV, Jonathan D, Veldman FJ, Nel JH (2005) Diet and blood pressure in South Africa: intake of foods containing sodium, potassium, calcium, and magnesium in three ethnic groups. Nutrition 21:39–50PubMedCrossRef Charlton KE, Steyn K, Levitt NS, Zulu JV, Jonathan D, Veldman FJ, Nel JH (2005) Diet and blood pressure in South Africa: intake of foods containing sodium, potassium, calcium, and magnesium in three ethnic groups. Nutrition 21:39–50PubMedCrossRef
54.
Zurück zum Zitat Bertram MY, Steyn K, Wentzel-Viljoen E, Tollman S, Hofman KJ (2012) Reducing the sodium content of high-salt foods: effect on cardiovascular disease in South Africa. S Afr Med J 102:743–745PubMedCrossRef Bertram MY, Steyn K, Wentzel-Viljoen E, Tollman S, Hofman KJ (2012) Reducing the sodium content of high-salt foods: effect on cardiovascular disease in South Africa. S Afr Med J 102:743–745PubMedCrossRef
55.
Zurück zum Zitat MacGregor GA, Markandu ND, Best FE, Elder DM, Cam JM, Sagnella GA, Squires M (1982) Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet 1:351–355PubMedCrossRef MacGregor GA, Markandu ND, Best FE, Elder DM, Cam JM, Sagnella GA, Squires M (1982) Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet 1:351–355PubMedCrossRef
56.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 289:2560–2572PubMedCrossRef Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 289:2560–2572PubMedCrossRef
57.
Zurück zum Zitat ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981–2997CrossRef ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981–2997CrossRef
58.
Zurück zum Zitat Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, Jamerson KA, Jones WE, Haywood J, Maxey R, Ofili EO, Saunders E, Schiffrin EL, Sica DA, Sowers JR, Vidt DG (2003) Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 163:525–541PubMedCrossRef Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, Jamerson KA, Jones WE, Haywood J, Maxey R, Ofili EO, Saunders E, Schiffrin EL, Sica DA, Sowers JR, Vidt DG (2003) Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 163:525–541PubMedCrossRef
59.
Zurück zum Zitat Cushman WC, Reda DJ, Perry HM, Williams D, Abdellatif M, Materson BJ (2000) Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 160:825–831PubMedCrossRef Cushman WC, Reda DJ, Perry HM, Williams D, Abdellatif M, Materson BJ (2000) Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 160:825–831PubMedCrossRef
60.
Zurück zum Zitat B Vogel, Kirschberger M, Zeier M. (2013). Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol Oct 15 (Epub ahead of print) B Vogel, Kirschberger M, Zeier M. (2013). Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol Oct 15 (Epub ahead of print)
61.
Zurück zum Zitat Sliwa K, Stewart S (2011) A low-cost solar-powered blood-pressure device. Lancet 378:647–648PubMedCrossRef Sliwa K, Stewart S (2011) A low-cost solar-powered blood-pressure device. Lancet 378:647–648PubMedCrossRef
62.
Zurück zum Zitat World Health Organization (2011) Noncommunicable disease country specific profiles 2011 (WHO Global Report) World Health Organization (2011) Noncommunicable disease country specific profiles 2011 (WHO Global Report)
Metadaten
Titel
Hypertension and hypertensive heart disease in African women
verfasst von
Karen Sliwa
Dike Ojji
Katrin Bachelier
Michael Böhm
Albertino Damasceno
Simon Stewart
Publikationsdatum
01.07.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 7/2014
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-014-0660-z

Weitere Artikel der Ausgabe 7/2014

Clinical Research in Cardiology 7/2014 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.